(2023). Prioritising cardiovascular disease risk assessment to high risk individuals based on primary care records. Plos One, 18, e0292240. http://doi.org/10.1371/journal.pone.0292240
. M. Arnold
First name
M.
Last name
Arnold
(2023). Rates of adverse clinical events in patients with chronic kidney disease: analysis of electronic health records from the UK clinical practice research datalink linked to hospital data. Bmc Nephrol, 24, 91. http://doi.org/10.1186/s12882-023-03119-z
. (2022). Healthcare resource utilisation and related costs of patients with CKD from the UK: a report from the DISCOVER CKD retrospective cohort. Clin Kidney J, 15, 2124-2134. http://doi.org/10.1093/ckj/sfac168
. (2022). Low Adherence to Kidney Disease: Improving Global Outcomes 2012 CKD Clinical Practice Guidelines Despite Clear Evidence of Utility. Kidney Int Rep, 7, 2059-2070. http://doi.org/10.1016/j.ekir.2022.05.033
. (2022). Incremental value of risk factor variability for cardiovascular risk prediction in individuals with type 2 diabetes: results from UK primary care electronic health records. Int J Epidemiol. http://doi.org/10.1093/ije/dyac140
. (2021). Polygenic risk scores in cardiovascular risk prediction: A cohort study and modelling analyses. PLoS Med. http://doi.org/10.1371/journal.pmed.1003498
. (2021). Prediction of Cardiovascular Disease Risk Accounting for Future Initiation of Statin Treatment. Am J Epidemiol. http://doi.org/10.1093/aje/kwab031
.